Amphastar hits BAQSIMI sales milestone, triggering $100 million payment to LillyAug 6Quarterly updateAmphastar Pharmaceuticals, Inc.Eli Lilly
Viatris-collaborated trial registered comparing Yupelri/Perforomist combo to standard COPD therapyJul 23Trial updateformoterolrevefenacin
Sign inSign in